The inflamed tumors might also harbor Tregs, myeloid-derived suppressor cells (MDSCs), B cells and cancer-associated fibroblasts (CAFs) which are generally inhibitory but PD-1/PD-L1 inhibitor administration is more likely to boost the CTL activity of this type of tumor than the other two “non-inflamed” phenotypes. Here, CD274 is linked to neoplasm.